世界のグリメピリドAPI市場インサイト・予測（～2027年）

• 英文タイトル：Global Glimepiride API Market Insights and Forecast to 2027

• レポートコード：QY2108PAL1258 • 出版社/出版日：QYResearch / 2021年8月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、108ページ • 納品方法：Eメール（納期：3日） • 産業分類：化学＆材料

• 販売価格（消費税別）

Single User	￥735,000 (USD4,900)	▷ お問い合わせ
Multi User	￥1,102,500 (USD7,350)	▷ お問い合わせ
Enterprise License	￥1,470,000 (USD9,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

本調査資料はグリメピリドAPIの世界市場の現状について調査・分析し、2027年までの市場を予測しました。グリメピリドAPIの世界市場概要、メーカー別の競争状況と市場シェア、種類別市場規模（純度≥98％、純度<98％）、用途別市場規模（グリメピリド錠、その他）、主要地域別市場規模（北米・アメリカ、ヨーロッパ、アジア・日本・中国・インド、中南米、中東・アフリカ）、関連企業の情報、バリューチェーン・販売チャネル、市場動向などを収録しています。 ・グリメピリドAPIの世界市場概要 ・メーカー別の競争状況、市場シェア ・グリメピリドAPIの種類別市場規模：純度≥98％、純度<98％ ・グリメピリドAPIの用途別市場規模：グリメピリド錠、その他 ・北米のグリメピリドAPI市場規模2016-2027：種類別、用途別、国別（アメリカ、カナダ） ・ヨーロッパのグリメピリドAPI市場規模2016-2027：種類別、用途別、国別（ドイツ、フランス、イギリス） ・アジアのグリメピリドAPI市場規模2016-2027：種類別、用途別、国別（日本、中国、インド、韓国） ・中南米のグリメピリドAPI市場規模2016-2027：種類別、用途別、国別（メキシコ、ブラジル） ・中東・アフリカのグリメピリドAPI市場規模2016-2027：種類別、用途別、国別（トルコ、サウジアラビア） ・企業情報：Dr. Reddy’s Laboratories Ltd.、SANOFI Active Ingredient Solutions、Dishman Carbogen Amcis、Glenmark Pharmaceuticals、Sharon Bio-Medicine Limited、Supra Chemicals、Rakshit Drugs、Estechpharma Co., Ltd.、Nishchem International Pvt. Ltd、Nexchem Pharmaceutical Co, ltd、Maps Laboratories Private Limited、CAD Middle East Pharmaceutical、Hanways Chempharm Co., Limited ・グリメピリドAPIのバリューチェーン・販売チャネル分析 ・グリメピリドAPIの世界市場動向

Glimepiride is a long-acting, third-generation sulfonylurea with hypoglycemic activity. Compared to other generations of sulfonylurea compounds, glimepiride is very potent and has a longer duration of action. This agent is metabolized by CYP2C9 and shows peroxisome proliferator-activated receptor gamma (PPARgamma) agonistic activity.

Market Analysis and Insights: Global Glimepiride API Market
The global Glimepiride API market is valued at US$ XX million in 2020. The market size will reach US$ XX million by the end of 2027, growing at a CAGR of XX% during 2021-2027.

Global Glimepiride API Scope and Segment
Glimepiride API market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Glimepiride API market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on production capacity, revenue and forecast by Type and by Application for the period 2016-2027.

Segment by Type
Purity≥98%
Purity<98% Segment by Application Glimepiride Tablets Others By Company Dr. Reddy’s Laboratories Ltd. SANOFI Active Ingredient Solutions Dishman Carbogen Amcis Glenmark Pharmaceuticals Sharon Bio-Medicine Limited Supra Chemicals Rakshit Drugs Estechpharma Co., Ltd. Nishchem International Pvt. Ltd Nexchem Pharmaceutical Co, ltd Maps Laboratories Private Limited CAD Middle East Pharmaceutical Hanways Chempharm Co., Limited Production by Region India Europe China South Korea Consumption by Region North America United States Canada Europe Germany France U.K. Italy Russia Asia-Pacific China Japan South Korea India Australia China Taiwan Indonesia Thailand Malaysia Latin America Mexico Brazil Argentina Middle East & Africa Turkey Saudi Arabia UAE

レポート目次

---

1 Study Coverage
1.1 Glimepiride API Product Introduction
1.2 Market by Type
1.2.1 Global Glimepiride API Market Size Growth Rate by Type
1.2.2 Purity≥98%
1.2.3 Purity<98% 1.3 Market by Application 1.3.1 Global Glimepiride API Market Size Growth Rate by Application 1.3.2 Glimepiride Tablets 1.3.3 Others 1.4 Study Objectives 1.5 Years Considered 2 Global Glimepiride API Production 2.1 Global Glimepiride API Production Capacity (2016-2027) 2.2 Global Glimepiride API Production by Region: 2016 VS 2021 VS 2027 2.3 Global Glimepiride API Production by Region 2.3.1 Global Glimepiride API Historic Production by Region (2016-2021) 2.3.2 Global Glimepiride API Forecasted Production by Region (2022-2027) 2.4 India 2.5 Europe 2.6 China 2.7 South Korea 3 Global Glimepiride API Sales in Volume & Value Estimates and Forecasts 3.1 Global Glimepiride API Sales Estimates and Forecasts 2016-2027 3.2 Global Glimepiride API Revenue Estimates and Forecasts 2016-2027 3.3 Global Glimepiride API Revenue by Region: 2016 VS 2021 VS 2027 3.4 Global Top Glimepiride API Regions by Sales 3.4.1 Global Top Glimepiride API Regions by Sales (2016-2021) 3.4.2 Global Top Glimepiride API Regions by Sales (2022-2027) 3.5 Global Top Glimepiride API Regions by Revenue 3.5.1 Global Top Glimepiride API Regions by Revenue (2016-2021) 3.5.2 Global Top Glimepiride API Regions by Revenue (2022-2027) 3.6 North America 3.7 Europe 3.8 Asia-Pacific 3.9 Latin America 3.10 Middle East & Africa 4 Competition by Manufactures 4.1 Global Glimepiride API Production Capacity by Manufacturers 4.2 Global Glimepiride API Sales by Manufacturers 4.2.1 Global Top Glimepiride API Manufacturers by Sales (2016-2021) 4.2.2 Global Top Glimepiride API Manufacturers Market Share by Sales (2016-2021) 4.2.3 Global Top 10 and Top 5 Companies by Glimepiride API Sales in 2020 4.3 Global Glimepiride API Revenue by Manufacturers 4.3.1 Global Top Glimepiride API Manufacturers by Revenue (2016-2021) 4.3.2 Global Top Glimepiride API Manufacturers Market Share by Revenue (2016-2021) 4.3.3 Global Top 10 and Top 5 Companies by Glimepiride API Revenue in 2020 4.4 Global Glimepiride API Sales Price by Manufacturers 4.5 Analysis of Competitive Landscape 4.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI) 4.5.2 Global Glimepiride API Market Share by Company Type (Tier 1, Tier 2, and Tier 3) 4.5.3 Global Glimepiride API Manufacturers Geographical Distribution 4.6 Mergers & Acquisitions, Expansion Plans 5 Market Size by Type 5.1 Global Glimepiride API Sales by Type 5.1.1 Global Glimepiride API Historical Sales by Type (2016-2021) 5.1.2 Global Glimepiride API Forecasted Sales by Type (2022-2027) 5.1.3 Global Glimepiride API Sales Market Share by Type (2016-2027) 5.2 Global Glimepiride API Revenue by Type 5.2.1 Global Glimepiride API Historical Revenue by Type (2016-2021) 5.2.2 Global Glimepiride API Forecasted Revenue by Type (2022-2027) 5.2.3 Global Glimepiride API Revenue Market Share by Type (2016-2027) 5.3 Global Glimepiride API Price by Type 5.3.1 Global Glimepiride API Price by Type (2016-2021) 5.3.2 Global Glimepiride API Price Forecast by Type (2022-2027) 6 Market Size by Application 6.1 Global Glimepiride API Sales by Application 6.1.1 Global Glimepiride API Historical Sales by Application (2016-2021) 6.1.2 Global Glimepiride API Forecasted Sales by Application (2022-2027) 6.1.3 Global Glimepiride API Sales Market Share by Application (2016-2027) 6.2 Global Glimepiride API Revenue by Application 6.2.1 Global Glimepiride API Historical Revenue by Application (2016-2021) 6.2.2 Global Glimepiride API Forecasted Revenue by Application (2022-2027) 6.2.3 Global Glimepiride API Revenue Market Share by Application (2016-2027) 6.3 Global Glimepiride API Price by Application 6.3.1 Global Glimepiride API Price by Application (2016-2021) 6.3.2 Global Glimepiride API Price Forecast by Application (2022-2027) 7 North America 7.1 North America Glimepiride API Market Size by Type 7.1.1 North America Glimepiride API Sales by Type (2016-2027) 7.1.2 North America Glimepiride API Revenue by Type (2016-2027) 7.2 North America Glimepiride API Market Size by Application 7.2.1 North America Glimepiride API Sales by Application (2016-2027) 7.2.2 North America Glimepiride API Revenue by Application (2016-2027) 7.3 North America Glimepiride API Sales by Country 7.3.1 North America Glimepiride API Sales by Country (2016-2027) 7.3.2 North America Glimepiride API Revenue by Country (2016-2027) 7.3.3 United States 7.3.4 Canada 8 Europe 8.1 Europe Glimepiride API Market Size by Type 8.1.1 Europe Glimepiride API Sales by Type (2016-2027) 8.1.2 Europe Glimepiride API Revenue by Type (2016-2027) 8.2 Europe Glimepiride API Market Size by Application 8.2.1 Europe Glimepiride API Sales by Application (2016-2027) 8.2.2 Europe Glimepiride API Revenue by Application (2016-2027) 8.3 Europe Glimepiride API Sales by Country 8.3.1 Europe Glimepiride API Sales by Country (2016-2027) 8.3.2 Europe Glimepiride API Revenue by Country (2016-2027) 8.3.3 Germany 8.3.4 France 8.3.5 U.K. 8.3.6 Italy 8.3.7 Russia 9 Asia Pacific 9.1 Asia Pacific Glimepiride API Market Size by Type 9.1.1 Asia Pacific Glimepiride API Sales by Type (2016-2027) 9.1.2 Asia Pacific Glimepiride API Revenue by Type (2016-2027) 9.2 Asia Pacific Glimepiride API Market Size by Application 9.2.1 Asia Pacific Glimepiride API Sales by Application (2016-2027) 9.2.2 Asia Pacific Glimepiride API Revenue by Application (2016-2027) 9.3 Asia Pacific Glimepiride API Sales by Region 9.3.1 Asia Pacific Glimepiride API Sales by Region (2016-2027) 9.3.2 Asia Pacific Glimepiride API Revenue by Region (2016-2027) 9.3.3 China 9.3.4 Japan 9.3.5 South Korea 9.3.6 India 9.3.7 Australia 9.3.8 China Taiwan 9.3.9 Indonesia 9.3.10 Thailand 9.3.11 Malaysia 10 Latin America 10.1 Latin America Glimepiride API Market Size by Type 10.1.1 Latin America Glimepiride API Sales by Type (2016-2027) 10.1.2 Latin America Glimepiride API Revenue by Type (2016-2027) 10.2 Latin America Glimepiride API Market Size by Application 10.2.1 Latin America Glimepiride API Sales by Application (2016-2027) 10.2.2 Latin America Glimepiride API Revenue by Application (2016-2027) 10.3 Latin America Glimepiride API Sales by Country 10.3.1 Latin America Glimepiride API Sales by Country (2016-2027) 10.3.2 Latin America Glimepiride API Revenue by Country (2016-2027) 10.3.3 Mexico 10.3.4 Brazil 10.3.5 Argentina 11 Middle East and Africa 11.1 Middle East and Africa Glimepiride API Market Size by Type 11.1.1 Middle East and Africa Glimepiride API Sales by Type (2016-2027) 11.1.2 Middle East and Africa Glimepiride API Revenue by Type (2016-2027) 11.2 Middle East and Africa Glimepiride API Market Size by Application 11.2.1 Middle East and Africa Glimepiride API Sales by Application (2016-2027) 11.2.2 Middle East and Africa Glimepiride API Revenue by Application (2016-2027) 11.3 Middle East and Africa Glimepiride API Sales by Country 11.3.1 Middle East and Africa Glimepiride API Sales by Country (2016-2027) 11.3.2 Middle East and Africa Glimepiride API Revenue by Country (2016-2027) 11.3.3 Turkey 11.3.4 Saudi Arabia 11.3.5 UAE 12 Corporate Profiles 12.1 Dr. Reddy’s Laboratories Ltd. 12.1.1 Dr. Reddy’s Laboratories Ltd. Corporation Information 12.1.2 Dr. Reddy’s Laboratories Ltd. Overview 12.1.3 Dr. Reddy’s Laboratories Ltd. Glimepiride API Sales, Price, Revenue and Gross Margin (2016-2021) 12.1.4 Dr. Reddy’s Laboratories Ltd. Glimepiride API Product Description 12.1.5 Dr. Reddy’s Laboratories Ltd. Recent Developments 12.2 SANOFI Active Ingredient Solutions 12.2.1 SANOFI Active Ingredient Solutions Corporation Information 12.2.2 SANOFI Active Ingredient Solutions Overview 12.2.3 SANOFI Active Ingredient Solutions Glimepiride API Sales, Price, Revenue and Gross Margin (2016-2021) 12.2.4 SANOFI Active Ingredient Solutions Glimepiride API Product Description 12.2.5 SANOFI Active Ingredient Solutions Recent Developments 12.3 Dishman Carbogen Amcis 12.3.1 Dishman Carbogen Amcis Corporation Information 12.3.2 Dishman Carbogen Amcis Overview 12.3.3 Dishman Carbogen Amcis Glimepiride API Sales, Price, Revenue and Gross Margin (2016-2021) 12.3.4 Dishman Carbogen Amcis Glimepiride API Product Description 12.3.5 Dishman Carbogen Amcis Recent Developments 12.4 Glenmark Pharmaceuticals 12.4.1 Glenmark Pharmaceuticals Corporation Information 12.4.2 Glenmark Pharmaceuticals Overview 12.4.3 Glenmark Pharmaceuticals Glimepiride API Sales, Price, Revenue and Gross Margin (2016-2021) 12.4.4 Glenmark Pharmaceuticals Glimepiride API Product Description 12.4.5 Glenmark Pharmaceuticals Recent Developments 12.5 Sharon Bio-Medicine Limited 12.5.1 Sharon Bio-Medicine Limited Corporation Information 12.5.2 Sharon Bio-Medicine Limited Overview 12.5.3 Sharon Bio-Medicine Limited Glimepiride API Sales, Price, Revenue and Gross Margin (2016-2021) 12.5.4 Sharon Bio-Medicine Limited Glimepiride API Product Description 12.5.5 Sharon Bio-Medicine Limited Recent Developments 12.6 Supra Chemicals 12.6.1 Supra Chemicals Corporation Information 12.6.2 Supra Chemicals Overview 12.6.3 Supra Chemicals Glimepiride API Sales, Price, Revenue and Gross Margin (2016-2021) 12.6.4 Supra Chemicals Glimepiride API Product Description 12.6.5 Supra Chemicals Recent Developments 12.7 Rakshit Drugs 12.7.1 Rakshit Drugs Corporation Information 12.7.2 Rakshit Drugs Overview 12.7.3 Rakshit Drugs Glimepiride API Sales, Price, Revenue and Gross Margin (2016-2021) 12.7.4 Rakshit Drugs Glimepiride API Product Description 12.7.5 Rakshit Drugs Recent Developments 12.8 Estechpharma Co., Ltd. 12.8.1 Estechpharma Co., Ltd. Corporation Information 12.8.2 Estechpharma Co., Ltd. Overview 12.8.3 Estechpharma Co., Ltd. Glimepiride API Sales, Price, Revenue and Gross Margin (2016-2021) 12.8.4 Estechpharma Co., Ltd. Glimepiride API Product Description 12.8.5 Estechpharma Co., Ltd. Recent Developments 12.9 Nishchem International Pvt. Ltd 12.9.1 Nishchem International Pvt. Ltd Corporation Information 12.9.2 Nishchem International Pvt. Ltd Overview 12.9.3 Nishchem International Pvt. Ltd Glimepiride API Sales, Price, Revenue and Gross Margin (2016-2021) 12.9.4 Nishchem International Pvt. Ltd Glimepiride API Product Description 12.9.5 Nishchem International Pvt. Ltd Recent Developments 12.10 Nexchem Pharmaceutical Co, ltd 12.10.1 Nexchem Pharmaceutical Co, ltd Corporation Information 12.10.2 Nexchem Pharmaceutical Co, ltd Overview 12.10.3 Nexchem Pharmaceutical Co, ltd Glimepiride API Sales, Price, Revenue and Gross Margin (2016-2021) 12.10.4 Nexchem Pharmaceutical Co, ltd Glimepiride API Product Description 12.10.5 Nexchem Pharmaceutical Co, ltd Recent Developments 12.11 Maps Laboratories Private Limited 12.11.1 Maps Laboratories Private Limited Corporation Information 12.11.2 Maps Laboratories Private Limited Overview 12.11.3 Maps Laboratories Private Limited Glimepiride API Sales, Price, Revenue and Gross Margin (2016-2021) 12.11.4 Maps Laboratories Private Limited Glimepiride API Product Description 12.11.5 Maps Laboratories Private Limited Recent Developments 12.12 CAD Middle East Pharmaceutical 12.12.1 CAD Middle East Pharmaceutical Corporation Information 12.12.2 CAD Middle East Pharmaceutical Overview 12.12.3 CAD Middle East Pharmaceutical Glimepiride API Sales, Price, Revenue and Gross Margin (2016-2021) 12.12.4 CAD Middle East Pharmaceutical Glimepiride API Product Description 12.12.5 CAD Middle East Pharmaceutical Recent Developments 12.13 Hanways Chempharm Co., Limited 12.13.1 Hanways Chempharm Co., Limited Corporation Information 12.13.2 Hanways Chempharm Co., Limited Overview 12.13.3 Hanways Chempharm Co., Limited Glimepiride API Sales, Price, Revenue and Gross Margin (2016-2021) 12.13.4 Hanways Chempharm Co., Limited Glimepiride API Product Description 12.13.5 Hanways Chempharm Co., Limited Recent Developments 13 Industry Chain and Sales Channels Analysis 13.1 Glimepiride API Industry Chain Analysis 13.2 Glimepiride API Key Raw Materials 13.2.1 Key Raw Materials 13.2.2 Raw Materials Key Suppliers 13.3 Glimepiride API Production Mode & Process 13.4 Glimepiride API Sales and Marketing 13.4.1 Glimepiride API Sales Channels 13.4.2 Glimepiride API Distributors 13.5 Glimepiride API Customers 14 Market Drivers, Opportunities, Challenges and Risks Factors Analysis 14.1 Glimepiride API Industry Trends 14.2 Glimepiride API Market Drivers 14.3 Glimepiride API Market Challenges 14.4 Glimepiride API Market Restraints 15 Key Finding in The Global Glimepiride API Study 16 Appendix 16.1 Research Methodology 16.1.1 Methodology/Research Approach 16.1.2 Data Source 16.2 Author Details 16.3 Disclaimer

List of Tables
Table 1. Global Glimepiride API Market Size Growth Rate by Type, 2016 VS 2021 VS 2027 (US$ Million)
Table 2. Major Manufacturers of Purity≥98%
Table 3. Major Manufacturers of Purity<98%
Table 4. Global Glimepiride API Market Size Growth Rate by Application, 2016 VS 2021 2027 (US$ Million)
Table 5. Global Glimepiride API Production by Region: 2016 VS 2021 VS 2027 (Ton)
Table 6. Global Glimepiride API Production by Region (2016-2021) & (Ton)
Table 7. Global Glimepiride API Production Market Share by Region (2016-2021)
Table 8. Global Glimepiride API Production by Region (2022-2027) & (Ton)
Table 9. Global Glimepiride API Production Market Share by Region (2022-2027)
Table 10. Global Glimepiride API Revenue by Region: 2016 VS 2021 VS 2027 (US$ Million)
Table 11. Global Glimepiride API Sales by Region (2016-2021) & (Ton)
Table 12. Global Glimepiride API Sales Market Share by Region (2016-2021)
Table 13. Global Glimepiride API Sales by Region (2022-2027) & (Ton)
Table 14. Global Glimepiride API Sales Market Share by Region (2022-2027)
Table 15. Global Glimepiride API Revenue by Region (2016-2021) & (US$ Million)
Table 16. Global Glimepiride API Revenue Market Share by Region (2016-2021)
Table 17. Global Glimepiride API Revenue by Region (2022-2027) & (US$ Million)
Table 18. Global Glimepiride API Revenue Market Share by Region (2022-2027)
Table 19. Global Glimepiride API Production Capacity by Manufacturers (2016-2021) & (Ton)
Table 20. Global Glimepiride API Capacity Market Share by Manufacturers (2016-2021)
Table 21. Global Glimepiride API Production by Manufacturers (2016-2021) & (Ton)
Table 22. Global Glimepiride API Production Market Share by Manufacturers (2016-2021)
Table 23. Global Glimepiride API Sales by Manufacturers (2016-2021) & (Ton)
Table 24. Global Glimepiride API Sales Share by Manufacturers (2016-2021)
Table 25. Global Glimepiride API Revenue by Manufacturers (2016-2021) & (US$ Million)
Table 26. Global Glimepiride API Revenue Share by Manufacturers (2016-2021)
Table 27. Glimepiride API Price by Manufacturers 2016-2021 (US$/Ton)
Table 28. Global Glimepiride API Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 29. Global Glimepiride API by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Glimepiride API as of 2020)
Table 30. Glimepiride API Manufacturing Base Distribution and Headquarters
Table 31. Manufacturers Glimepiride API Product Offered
Table 32. Date of Manufacturers Enter into Glimepiride API Market
Table 33. Mergers & Acquisitions, Expansion Plans
Table 34. Global Glimepiride API Sales by Type (2016-2021) & (Ton)
Table 35. Global Glimepiride API Sales by Type (2022-2027) & (Ton)
Table 36. Global Glimepiride API Sales Share by Type (2016-2021)
Table 37. Global Glimepiride API Sales Share by Type (2022-2027)
Table 38. Global Glimepiride API Revenue by Type (2016-2021) & (US$ Million)
Table 39. Global Glimepiride API Revenue by Type (2022-2027) & (US$ Million)
Table 40. Global Glimepiride API Revenue Share by Type (2016-2021)
Table 41. Global Glimepiride API Revenue Share by Type (2022-2027)
Table 42. Glimepiride API Price by Type (2016-2021) & (US$/Ton)
Table 43. Global Glimepiride API Price Forecast by Type (2022-2027) & (US$/Ton)
Table 44. Global Glimepiride API Sales by Application (2016-2021) & (Ton)
Table 45. Global Glimepiride API Sales by Application (2022-2027) & (Ton)
Table 46. Global Glimepiride API Sales Share by Application (2016-2021)
Table 47. Global Glimepiride API Sales Share by Application (2022-2027)
Table 48. Global Glimepiride API Revenue by Application (2016-2021) & (US$ Million)
Table 49. Global Glimepiride API Revenue by Application (2022-2027) & (US$ Million)
Table 50. Global Glimepiride API Revenue Share by Application (2016-2021)
Table 51. Global Glimepiride API Revenue Share by Application (2022-2027)
Table 52. Glimepiride API Price by Application (2016-2021) & (US$/Ton)
Table 53. Global Glimepiride API Price Forecast by Application (2022-2027) & (US$/Ton)
Table 54. North America Glimepiride API Sales by Type (2016-2021) & (Ton)
Table 55. North America Glimepiride API Sales by Type (2022-2027) & (Ton)
Table 56. North America Glimepiride API Revenue by Type (2016-2021) & (US$ Million)
Table 57. North America Glimepiride API Revenue by Type (2022-2027) & (US$ Million)
Table 58. North America Glimepiride API Sales by Application (2016-2021) & (Ton)
Table 59. North America Glimepiride API Sales by Application (2022-2027) & (Ton)
Table 60. North America Glimepiride API Revenue by Application (2016-2021) & (US$ Million)
Table 61. North America Glimepiride API Revenue by Application (2022-2027) & (US$ Million)
Table 62. North America Glimepiride API Sales by Country (2016-2021) & (Ton)
Table 63. North America Glimepiride API Sales by Country (2022-2027) & (Ton)
Table 64. North America Glimepiride API Revenue by Country (2016-2021) & (US$ Million)
Table 65. North America Glimepiride API Revenue by Country (2022-2027) & (US$ Million)
Table 66. Europe Glimepiride API Sales by Type (2016-2021) & (Ton)
Table 67. Europe Glimepiride API Sales by Type (2022-2027) & (Ton)
Table 68. Europe Glimepiride API Revenue by Type (2016-2021) & (US$ Million)
Table 69. Europe Glimepiride API Revenue by Type (2022-2027) & (US$ Million)
Table 70. Europe Glimepiride API Sales by Application (2016-2021) & (Ton)
Table 71. Europe Glimepiride API Sales by Application (2022-2027) & (Ton)
Table 72. Europe Glimepiride API Revenue by Application (2016-2021) & (US$ Million)
Table 73. Europe Glimepiride API Revenue by Application (2022-2027) & (US$ Million)
Table 74. Europe Glimepiride API Sales by Country (2016-2021) & (Ton)
Table 75. Europe Glimepiride API Sales by Country (2022-2027) & (Ton)
Table 76. Europe Glimepiride API Revenue by Country (2016-2021) & (US$ Million)
Table 77. Europe Glimepiride API Revenue by Country (2022-2027) & (US$ Million)
Table 78. Asia Pacific Glimepiride API Sales by Type (2016-2021) & (Ton)
Table 79. Asia Pacific Glimepiride API Sales by Type (2022-2027) & (Ton)
Table 80. Asia Pacific Glimepiride API Revenue by Type (2016-2021) & (US$ Million)
Table 81. Asia Pacific Glimepiride API Revenue by Type (2022-2027) & (US$ Million)
Table 82. Asia Pacific Glimepiride API Sales by Application (2016-2021) & (Ton)
Table 83. Asia Pacific Glimepiride API Sales by Application (2022-2027) & (Ton)
Table 84. Asia Pacific Glimepiride API Revenue by Application (2016-2021) & (US$ Million)
Table 85. Asia Pacific Glimepiride API Revenue by Application (2022-2027) & (US$ Million)
Table 86. Asia Pacific Glimepiride API Sales by Region (2016-2021) & (Ton)
Table 87. Asia Pacific Glimepiride API Sales by Region (2022-2027) & (Ton)
Table 88. Asia Pacific Glimepiride API Revenue by Region (2016-2021) & (US$ Million)
Table 89. Asia Pacific Glimepiride API Revenue by Region (2022-2027) & (US$ Million)
Table 90. Latin America Glimepiride API Sales by Type (2016-2021) & (Ton)
Table 91. Latin America Glimepiride API Sales by Type (2022-2027) & (Ton)
Table 92. Latin America Glimepiride API Revenue by Type (2016-2021) & (US$ Million)
Table 93. Latin America Glimepiride API Revenue by Type (2022-2027) & (US$ Million)
Table 94. Latin America Glimepiride API Sales by Application (2016-2021) & (Ton)
Table 95. Latin America Glimepiride API Sales by Application (2022-2027) & (Ton)
Table 96. Latin America Glimepiride API Revenue by Application (2016-2021) & (US$ Million)
Table 97. Latin America Glimepiride API Revenue by Application (2022-2027) & (US$ Million)
Table 98. Latin America Glimepiride API Sales by Country (2016-2021) & (Ton)
Table 99. Latin America Glimepiride API Sales by Country (2022-2027) & (Ton)
Table 100. Latin America Glimepiride API Revenue by Country (2016-2021) & (US$ Million)
Table 101. Latin America Glimepiride API Revenue by Country (2022-2027) & (US$ Million)
Table 102. Middle East and Africa Glimepiride API Sales by Type (2016-2021) & (Ton)
Table 103. Middle East and Africa Glimepiride API Sales by Type (2022-2027) & (Ton)
Table 104. Middle East and Africa Glimepiride API Revenue by Type (2016-2021) & (US$ Million)
Table 105. Middle East and Africa Glimepiride API Revenue by Type (2022-2027) & (US$ Million)
Table 106. Middle East and Africa Glimepiride API Sales by Application (2016-2021) & (Ton)
Table 107. Middle East and Africa Glimepiride API Sales by Application (2022-2027) & (Ton)
Table 108. Middle East and Africa Glimepiride API Revenue by Application (2016-2021) & (US$ Million)
Table 109. Middle East and Africa Glimepiride API Revenue by Application (2022-2027) & (US$ Million)
Table 110. Middle East and Africa Glimepiride API Sales by Country (2016-2021) & (Ton)
Table 111. Middle East and Africa Glimepiride API Sales by Country (2022-2027) & (Ton)
Table 112. Middle East and Africa Glimepiride API Revenue by Country (2016-2021) & (US$ Million)
Table 113. Middle East and Africa Glimepiride API Revenue by Country (2022-2027) & (US$ Million)
Table 114. Dr. Reddy’s Laboratories Ltd. Corporation Information
Table 115. Dr. Reddy’s Laboratories Ltd. Description and Major Businesses
Table 116. Dr. Reddy’s Laboratories Ltd. Glimepiride API Sales (Ton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2016-2021)
Table 117. Dr. Reddy’s Laboratories Ltd. Glimepiride API Product
Table 118. Dr. Reddy’s Laboratories Ltd. Recent Development
Table 119. SANOFI Active Ingredient Solutions Corporation Information
Table 120. SANOFI Active Ingredient Solutions Description and Major Businesses
Table 121. SANOFI Active Ingredient Solutions Glimepiride API Sales (Ton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2016-2021)
Table 122. SANOFI Active Ingredient Solutions Glimepiride API Product
Table 123. SANOFI Active Ingredient Solutions Recent Development
Table 124. Dishman Carbogen Amcis Corporation Information
Table 125. Dishman Carbogen Amcis Description and Major Businesses
Table 126. Dishman Carbogen Amcis Glimepiride API Sales (Ton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2016-2021)
Table 127. Dishman Carbogen Amcis Glimepiride API Product
Table 128. Dishman Carbogen Amcis Recent Development
Table 129. Glenmark Pharmaceuticals Corporation Information
Table 130. Glenmark Pharmaceuticals Description and Major Businesses
Table 131. Glenmark Pharmaceuticals Glimepiride API Sales (Ton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2016-2021)
Table 132. Glenmark Pharmaceuticals Glimepiride API Product
Table 133. Glenmark Pharmaceuticals Recent Development
Table 134. Sharon Bio-Medicine Limited Corporation Information
Table 135. Sharon Bio-Medicine Limited Description and Major Businesses
Table 136. Sharon Bio-Medicine Limited Glimepiride API Sales (Ton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2016-2021)
Table 137. Sharon Bio-Medicine Limited Glimepiride API Product
Table 138. Sharon Bio-Medicine Limited Recent Development
Table 139. Supra Chemicals Corporation Information
Table 140. Supra Chemicals Description and Major Businesses
Table 141. Supra Chemicals Glimepiride API Sales (Ton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2016-2021)
Table 142. Supra Chemicals Glimepiride API Product
Table 143. Supra Chemicals Recent Development
Table 144. Rakshit Drugs Corporation Information
Table 145. Rakshit Drugs Description and Major Businesses
Table 146. Rakshit Drugs Glimepiride API Sales (Ton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2016-2021)
Table 147. Rakshit Drugs Glimepiride API Product
Table 148. Rakshit Drugs Recent Development
Table 149. Estechpharma Co., Ltd. Corporation Information
Table 150. Estechpharma Co., Ltd. Description and Major Businesses
Table 151. Estechpharma Co., Ltd. Glimepiride API Sales (Ton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2016-2021)
Table 152. Estechpharma Co., Ltd. Glimepiride API Product
Table 153. Estechpharma Co., Ltd. Recent Development
Table 154. Nishchem International Pvt. Ltd Corporation Information
Table 155. Nishchem International Pvt. Ltd Description and Major Businesses
Table 156. Nishchem International Pvt. Ltd Glimepiride API Sales (Ton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2016-2021)
Table 157. Nishchem International Pvt. Ltd Glimepiride API Product
Table 158. Nishchem International Pvt. Ltd Recent Development
Table 159. Nexchem Pharmaceutical Co, ltd Corporation Information
Table 160. Nexchem Pharmaceutical Co, ltd Description and Major Businesses
Table 161. Nexchem Pharmaceutical Co, ltd Glimepiride API Sales (Ton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2016-2021)
Table 162. Nexchem Pharmaceutical Co, ltd Glimepiride API Product
Table 163. Nexchem Pharmaceutical Co, ltd Recent Development
Table 164. Maps Laboratories Private Limited Corporation Information
Table 165. Maps Laboratories Private Limited Description and Major Businesses
Table 166. Maps Laboratories Private Limited Glimepiride API Sales (Ton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2016-2021)
Table 167. Maps Laboratories Private Limited Glimepiride API Product
Table 168. Maps Laboratories Private Limited Recent Development
Table 169. CAD Middle East Pharmaceutical Corporation Information
Table 170. CAD Middle East Pharmaceutical Description and Major Businesses
Table 171. CAD Middle East Pharmaceutical Glimepiride API Sales (Ton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2016-2021)
Table 172. CAD Middle East Pharmaceutical Glimepiride API Product
Table 173. CAD Middle East Pharmaceutical Recent Development
Table 174. Hanways Chempharm Co., Limited Corporation Information
Table 175. Hanways Chempharm Co., Limited Description and Major Businesses
Table 176. Hanways Chempharm Co., Limited Glimepiride API Sales (Ton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2016-2021)
Table 177. Hanways Chempharm Co., Limited Glimepiride API Product
Table 178. Hanways Chempharm Co., Limited Recent Development
Table 179. Key Raw Materials Lists
Table 180. Raw Materials Key Suppliers Lists
Table 181. Glimepiride API Distributors List
Table 182. Glimepiride API Customers List
Table 183. Glimepiride API Market Trends
Table 184. Glimepiride API Market Drivers
Table 185. Glimepiride API Market Challenges
Table 186. Glimepiride API Market Restraints
Table 187. Research Programs/Design for This Report
Table 188. Key Data Information from Secondary Sources
Table 189. Key Data Information from Primary Sources
List of Figures
Figure 1. Glimepiride API Product Picture
Figure 2. Global Glimepiride API Market Share by Type in 2020 & 2027
Figure 3. Purity≥98% Product Picture
Figure 4. Purity<98% Product Picture
Figure 5. Global Glimepiride API Market Share by Application in 2020 & 2027
Figure 6. Glimepiride Tablets
Figure 7. Others
Figure 8. Glimepiride API Report Years Considered
Figure 9. Global Glimepiride API Capacity, Production and Utilization (2016-2027) & (Ton)
Figure 10. Global Glimepiride API Production Market Share by Region in Percentage: 2020 Versus 2027
Figure 11. Global Glimepiride API Production Market Share by Region (2016-2021)
Figure 12. Global Glimepiride API Production Market Share by Region (2022-2027)
Figure 13. Glimepiride API Production Growth Rate in India (2016-2027) & (Ton)
Figure 14. Glimepiride API Production Growth Rate in Europe (2016-2027) & (Ton)
Figure 15. Glimepiride API Production Growth Rate in China (2016-2027) & (Ton)
Figure 16. Glimepiride API Production Growth Rate in South Korea (2016-2027) & (Ton)
Figure 17. Global Glimepiride API Sales 2016-2027 (Ton)
Figure 18. Global Glimepiride API Revenue, (US$ Million), 2016 VS 2021 VS 2027
Figure 19. Global Glimepiride API Revenue 2016-2027 (US$ Million)
Figure 20. Global Glimepiride API Revenue Market Share by Region in Percentage: 2020 Versus 2027
Figure 21. Global Glimepiride API Sales Market Share by Region (2016-2021)
Figure 22. Global Glimepiride API Sales Market Share by Region (2022-2027)
Figure 23. North America Glimepiride API Sales YoY (2016-2027) & (Ton)
Figure 24. North America Glimepiride API Revenue YoY (2016-2027) & (US$ Million)
Figure 25. Europe Glimepiride API Sales YoY (2016-2027) & (Ton)
Figure 26. Europe Glimepiride API Revenue YoY (2016-2027) & (US$ Million)
Figure 27. Asia-Pacific Glimepiride API Sales YoY (2016-2027) & (Ton)
Figure 28. Asia-Pacific Glimepiride API Revenue YoY (2016-2027) & (US$ Million)
Figure 29. Latin America Glimepiride API Sales YoY (2016-2027) & (Ton)
Figure 30. Latin America Glimepiride API Revenue YoY (2016-2027) & (US$ Million)
Figure 31. Middle East & Africa Glimepiride API Sales YoY (2016-2027) & (Ton)
Figure 32. Middle East & Africa Glimepiride API Revenue YoY (2016-2027) & (US$ Million)
Figure 33. The Top 10 and Top 5 Players Market Share by Glimepiride API Sales in 2020
Figure 34. The Top 10 and Top 5 Players Market Share by Glimepiride API Revenue in 2020
Figure 35. Glimepiride API Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2016 VS 2020
Figure 36. Global Glimepiride API Sales Market Share by Type (2016-2027)
Figure 37. Global Glimepiride API Revenue Market Share by Type (2016-2027)
Figure 38. Global Glimepiride API Sales Market Share by Application (2016-2027)
Figure 39. Global Glimepiride API Revenue Market Share by Application (2016-2027)
Figure 40. North America Glimepiride API Sales Market Share by Type (2016-2027)
Figure 41. North America Glimepiride API Revenue Market Share by Type (2016-2027)
Figure 42. North America Glimepiride API Sales Market Share by Application (2016-2027)
Figure 43. North America Glimepiride API Revenue Market Share by Application (2016-2027)
Figure 44. North America Glimepiride API Sales Share by Country (2016-2027)
Figure 45. North America Glimepiride API Revenue Share by Country (2016-2027)
Figure 46. United States Glimepiride API Revenue (2016-2027) & (US$ Million)
Figure 47. Canada Glimepiride API Revenue (2016-2027) & (US$ Million)
Figure 48. Europe Glimepiride API Sales Market Share by Type (2016-2027)
Figure 49. Europe Glimepiride API Revenue Market Share by Type (2016-2027)
Figure 50. Europe Glimepiride API Sales Market Share by Application (2016-2027)
Figure 51. Europe Glimepiride API Revenue Market Share by Application (2016-2027)
Figure 52. Europe Glimepiride API Sales Share by Country (2016-2027)
Figure 53. Europe Glimepiride API Revenue Share by Country (2016-2027)
Figure 54. Germany Glimepiride API Revenue (2016-2027) & (US$ Million)
Figure 55. France Glimepiride API Revenue (2016-2027) & (US$ Million)
Figure 56. U.K. Glimepiride API Revenue (2016-2027) & (US$ Million)
Figure 57. Italy Glimepiride API Revenue (2016-2027) & (US$ Million)
Figure 58. Russia Glimepiride API Revenue (2016-2027) & (US$ Million)
Figure 59. Asia Pacific Glimepiride API Sales Market Share by Type (2016-2027)
Figure 60. Asia Pacific Glimepiride API Revenue Market Share by Type (2016-2027)
Figure 61. Asia Pacific Glimepiride API Sales Market Share by Application (2016-2027)
Figure 62. Asia Pacific Glimepiride API Revenue Market Share by Application (2016-2027)
Figure 63. Asia Pacific Glimepiride API Sales Share by Region (2016-2027)
Figure 64. Asia Pacific Glimepiride API Revenue Share by Region (2016-2027)
Figure 65. China Glimepiride API Revenue (2016-2027) & (US$ Million)
Figure 66. Japan Glimepiride API Revenue (2016-2027) & (US$ Million)
Figure 67. South Korea Glimepiride API Revenue (2016-2027) & (US$ Million)
Figure 68. India Glimepiride API Revenue (2016-2027) & (US$ Million)
Figure 69. Australia Glimepiride API Revenue (2016-2027) & (US$ Million)
Figure 70. China Taiwan Glimepiride API Revenue (2016-2027) & (US$ Million)
Figure 71. Indonesia Glimepiride API Revenue (2016-2027) & (US$ Million)
Figure 72. Thailand Glimepiride API Revenue (2016-2027) & (US$ Million)
Figure 73. Malaysia Glimepiride API Revenue (2016-2027) & (US$ Million)
Figure 74. Latin America Glimepiride API Sales Market Share by Type (2016-2027)
Figure 75. Latin America Glimepiride API Revenue Market Share by Type (2016-2027)
Figure 76. Latin America Glimepiride API Sales Market Share by Application (2016-2027)
Figure 77. Latin America Glimepiride API Revenue Market Share by Application (2016-2027)
Figure 78. Latin America Glimepiride API Sales Share by Country (2016-2027)
Figure 79. Latin America Glimepiride API Revenue Share by Country (2016-2027)
Figure 80. Mexico Glimepiride API Revenue (2016-2027) & (US$ Million)
Figure 81. Brazil Glimepiride API Revenue (2016-2027) & (US$ Million)
Figure 82. Argentina Glimepiride API Revenue (2016-2027) & (US$ Million)
Figure 83. Middle East and Africa Glimepiride API Sales Market Share by Type (2016-2027)
Figure 84. Middle East and Africa Glimepiride API Revenue Market Share by Type (2016-2027)
Figure 85. Middle East and Africa Glimepiride API Sales Market Share by Application (2016-2027)
Figure 86. Middle East and Africa Glimepiride API Revenue Market Share by Application (2016-2027)
Figure 87. Middle East and Africa Glimepiride API Sales Share by Country (2016-2027)
Figure 88. Middle East and Africa Glimepiride API Revenue Share by Country (2016-2027)
Figure 89. Turkey Glimepiride API Revenue (2016-2027) & (US$ Million)
Figure 90. Saudi Arabia Glimepiride API Revenue (2016-2027) & (US$ Million)
Figure 91. UAE Glimepiride API Revenue (2016-2027) & (US$ Million)
Figure 92. Glimepiride API Value Chain
Figure 93. Glimepiride API Production Process
Figure 94. Channels of Distribution
Figure 95. Distributors Profiles
Figure 96. Bottom-up and Top-down Approaches for This Report
Figure 97. Data Triangulation
Figure 98. Key Executives Interviewed

---